NeuroBo Pharmaceuticals Inc (NRBO)
3.38
-0.08
(-2.31%)
USD |
NASDAQ |
Apr 18, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Cash from Operations (TTM): -10.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.80M |
| September 30, 2023 | -9.213M |
| June 30, 2023 | -8.758M |
| March 31, 2023 | -9.43M |
| December 31, 2022 | -11.71M |
| September 30, 2022 | -12.80M |
| June 30, 2022 | -12.95M |
| March 31, 2022 | -13.82M |
| December 31, 2021 | -15.13M |
| September 30, 2021 | -14.58M |
| June 30, 2021 | -14.03M |
| March 31, 2021 | -12.77M |
| December 31, 2020 | -10.76M |
| September 30, 2020 | -9.694M |
| June 30, 2020 | -11.08M |
| March 31, 2020 | -9.953M |
| December 31, 2019 | -7.039M |
| Date | Value |
|---|---|
| September 30, 2019 | -2.414M |
| June 30, 2019 | -3.353M |
| March 31, 2019 | -8.439M |
| December 31, 2018 | -14.45M |
| September 30, 2018 | -24.56M |
| June 30, 2018 | -27.57M |
| March 31, 2018 | -27.91M |
| December 31, 2017 | -26.90M |
| September 30, 2017 | -23.76M |
| June 30, 2017 | -20.10M |
| March 31, 2017 | -15.21M |
| December 31, 2016 | -11.04M |
| September 30, 2016 | -9.676M |
| June 30, 2016 | -7.604M |
| March 31, 2016 | -6.869M |
| December 31, 2015 | -5.433M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-15.13M
Minimum
Dec 2021
-2.414M
Maximum
Sep 2019
-10.54M
Average
-10.80M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
| Conmed Corp | 125.35M |
| Eli Lilly and Co | 4.240B |
| Alaunos Therapeutics Inc | -30.14M |
| Lipocine Inc | -11.87M |
| Relmada Therapeutics Inc | -51.66M |